Kristie Ann Wagner is VP, Principal Fin & Acct Off of Entasis Therapeutics Holdings Inc.. Currently has a direct ownership of 0 shares of ETTX, which is worth approximately $0. The most recent transaction as insider was on Jul 11, 2022, when has been sold 80,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Kristie Ann Wagner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 11 2022
SELL
Sale (or disposition) back to the issuer
-
80,500 Reduced 100.0%
0 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 11.05%
80,500 Common Stock
KAW

Kristie Ann Wagner

VP, Principal Fin & Acct Off
Waltham, MA

Track Institutional and Insider Activities on ETTX

Follow Entasis Therapeutics Holdings Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETTX shares.

Notify only if

Insider Trading

Get notified when an Entasis Therapeutics Holdings Inc. insider buys or sells ETTX shares.

Notify only if

News

Receive news related to Entasis Therapeutics Holdings Inc.

Track Activities on ETTX